Karen Jean Ferrante
Director · 5 filings · Latest: Oct 1, 2026
Cogent Biosciences, Inc.
MACROGENICS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MGNX | Karen Jean Ferrante | Director | May 18, 2026 | Option Exercise | — | 3,750 | — | 14,750 |